Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Improving Donor Selection for Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide through Selective HLA-Mis/Matching

Ephraim J. Fuchs, MD MBA, Shannon R McCurdy, MD, Scott R. Solomon, MD, Tao Wang, PhD, Michelle Kuxhausen, MS, Yvette L Kasamon, MD, MHD Monzr Al Malki, MD, Shahinaz Gadalla, MD PhD, Sophie Paczesny, MDPhD, Steven GE Marsh, BSc, PhD ARCS, Bronwen E. Shaw, PhD MRCP, FRCPath, Stephen R. Spellman, MS, Stephanie J. Lee, MDMPH, Effie Petersdorf, MD

Blood (2020) 136 (Supplement 1): 24–26.

https://doi.org/10.1182/blood-2020-140433

Published: 2020

Journal Articles

What Do Transplant Physicians Think about Palliative Care? A National Survey Study

Areej El-Jawahri, MD, Thomas W. LeBlanc, MD MA, Linda J. Burns, MD, Ellen Denzen, MS, Christa Lea Meyer, MS, Lih-Wen Mau, PhD MPH, Eric J. Roeland, MD, William A. Wood, MD MPH, Effie Petersdorf, MD

Blood (2017) 130 (Supplement 1): 3388.

https://doi.org/10.1182/blood.V130.Suppl_1.3388.3388

Published: 2017

Journal Articles

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

Jeffrey M. Venstrom, Ted A. Gooley, Stephen Spellman, James Pring, Mari Malkki, Bo Dupont, Effie Petersdorf, Katharine C. Hsu

Blood (2010) 115 (15): 3162–3165.

https://doi.org/10.1182/blood-2009-08-236943

Published: 2010

Includes: Supplemental data

Journal Articles

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

Stephanie J. Lee, John Klein, Michael Haagenson, Lee Ann Baxter-Lowe, Dennis L. Confer, Mary Eapen, Marcelo Fernandez-Vina, Neal Flomenberg, Mary Horowitz, Carolyn K. Hurley, Harriet Noreen, Machteld Oudshoorn, Effie Petersdorf, Michelle Setterholm, Stephen Spellman, Daniel Weisdorf, Thomas M. Williams, Claudio Anasetti

Blood (2007) 110 (13): 4576–4583.

https://doi.org/10.1182/blood-2007-06-097386

Published: 2007

Includes: Supplemental data

Journal Articles

High Resolution HLA Matched Unrelated Donor Versus HLA Identical Sibling Transplantation for Chronic Phase CML.

Mukta Arora, MD, MS, Stephen Spellman, MBS, Michael Haagenson, MS, John P. Klein, PhD, Carolyn Hurley, PhD, George Selby, MD, Joseph Antin, MD, Nancy Kernan, MD, Craig Kollman, PhD, Auayporn Nademanee, MD, Daniel J. Weisdorf, MD, Mary M. Horowitz, MD, MS, Philip McGlave, MD, Effie Petersdorf, MD

Blood (2007) 110 (11): 171.

https://doi.org/10.1182/blood.V110.11.171.171

Published: 2007

Journal Articles

Low-Dose Total Body Irradiation (TBI) and Fludarabine Conditioning for Hematopoietic Cell Transplantation (HCT) in Patients with HLA-Class I Mismatched Donors.

Hirohisa Nakamae, Barry Storer, Thomas Chauncey, Michael Pulsipher, Finn Petersen, James C. Wade, Michael Maris, Ben Bruno, Effie Petersdorf, David Maloney, Rainer Storb, Brenda M. Sandmaier

Blood (2007) 110 (11): 3067.

https://doi.org/10.1182/blood.V110.11.3067.3067

Published: 2007

Journal Articles

Postgrafting Immunosuppression with Prolonged Mycophenolate Mofetil (MMF) and Truncated Cyclosporine (CSP) Failed To Reduce the Incidence of Graft-Versus-Host Disease (GVHD) after Unrelated Donor Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning.

Frederic Baron, Brenda M. Sandmaier, Barry Storer, Michael Maris, Amelia Langston, Dietger W. Niederwieser, Effie Petersdorf, Wolfgang Bethge, Richard T. Maziarz, Peter McSweeney, Michael Pulsipher, James C. Wade, Thomas Chauncey, Judith Shizuru, Ann Woolfrey, David G. Maloney, Rainer F. Storb

Blood (2006) 108 (11): 3119.

https://doi.org/10.1182/blood.V108.11.3119.3119

Published: 2006

Journal Articles

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

Stephanie J. Lee, MD, MPH, John Klein, PhD, Michael Haagenson, MS, Lee Ann Baxter-Lowe, PhD, Dennis Confer, MD, Mary Eapen, MBBS, Marcelo Fernandez-Vina, PhD, Neal Flomenberg, MD, Mary Horowitz, MD, Carolyn Hurley, PhD, Harriet Noreen, CHS, Machteld Oudshoorn, PhD, Effie Petersdorf, MD, Michelle Setterholm, MS, Stephen Spellman, MS, Daniel Weisdorf, MD, Thomas M. Williams, MD, Claudio Anasetti, MD

Blood (2006) 108 (11): 172.

https://doi.org/10.1182/blood.V108.11.172.172

Published: 2006

Journal Articles

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

Neal Flomenberg, Lee Ann Baxter-Lowe, Dennis Confer, Marcelo Fernandez-Vina, Alexandra Filipovich, Mary Horowitz, Carolyn Hurley, Craig Kollman, Claudio Anasetti, Harriet Noreen, Ann Begovich, William Hildebrand, Effie Petersdorf, Barbara Schmeckpeper, Michelle Setterholm, Elizabeth Trachtenberg, Thomas Williams, Edmond Yunis, Daniel Weisdorf

Blood (2004) 104 (7): 1923–1930.

https://doi.org/10.1182/blood-2004-03-0803

Published: 2004

Journal Articles

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Michael B. Maris, Dietger Niederwieser, Brenda M. Sandmaier, Barry Storer, Monic Stuart, David Maloney, Effie Petersdorf, Peter McSweeney, Michael Pulsipher, Ann Woolfrey, Thomas Chauncey, Ed Agura, Shelly Heimfeld, John Slattery, Ute Hegenbart, Claudio Anasetti, Karl Blume, Rainer Storb

Blood (2003) 102 (6): 2021–2030.

https://doi.org/10.1182/blood-2003-02-0482

Published: 2003

Journal Articles

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

Dietger Niederwieser, Michael Maris, Judith A. Shizuru, Effie Petersdorf, Ute Hegenbart, Brenda M. Sandmaier, David G. Maloney, Barry Storer, Thoralf Lange, Thomas Chauncey, Michael Deininger, Wolfram Pönisch, Claudio Anasetti, Ann Woolfrey, Marie-Terese Little, Karl G. Blume, Peter A. McSweeney, Rainer F. Storb

Blood (2003) 101 (4): 1620–1629.

https://doi.org/10.1182/blood-2002-05-1340

Published: 2003

Journal Articles

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome

H. Joachim Deeg, Barry Storer, John T. Slattery, Claudio Anasetti, Kristine C. Doney, John A. Hansen, Hans-Peter Kiem, Paul J. Martin, Effie Petersdorf, Jerald P. Radich, Jean E. Sanders, Howard M. Shulman, Edus H. Warren, Robert P. Witherspoon, Eileen M. Bryant, Thomas R. Chauncey, Lisa Getzendaner, Rainer Storb, Frederick R. Appelbaum

Blood (2002) 100 (4): 1201–1207.

https://doi.org/10.1182/blood-2002-02-0527

Published: 2002

Journal Articles

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children

Ann E. Woolfrey, Claudio Anasetti, Barry Storer, Kristine Doney, Laurie A. Milner, Eric L. Sievers, Paul Carpenter, Paul Martin, Effie Petersdorf, Frederick R. Appelbaum, John A. Hansen, Jean E. Sanders

Blood (2002) 99 (6): 2002–2008.

https://doi.org/10.1182/blood.V99.6.2002

Published: 2002

Journal Articles

Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation

Daniel J. Weisdorf, Claudio Anasetti, Joseph H. Antin, Nancy A. Kernan, Craig Kollman, David Snyder, Effie Petersdorf, Gene Nelson, Philip McGlave

Blood (2002) 99 (6): 1971–1977.

https://doi.org/10.1182/blood.V99.6.1971

Published: 2002

Journal Articles

Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV + Hodgkin's Disease

Amy P. Sing, Richard F. Ambinder, Doley J. Hong, Michael Jensen, Wendy Batten, Effie Petersdorf, Philip D. Greenberg

Blood (1997) 89 (6): 1978–1986.

https://doi.org/10.1182/blood.V89.6.1978

Published: 1997

NARROW

Improving Donor Selection for Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide through Selective HLA-Mis/Matching

What Do Transplant Physicians Think about Palliative Care? A National Survey Study

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

High Resolution HLA Matched Unrelated Donor Versus HLA Identical Sibling Transplantation for Chronic Phase CML.

Low-Dose Total Body Irradiation (TBI) and Fludarabine Conditioning for Hematopoietic Cell Transplantation (HCT) in Patients with HLA-Class I Mismatched Donors.

Postgrafting Immunosuppression with Prolonged Mycophenolate Mofetil (MMF) and Truncated Cyclosporine (CSP) Failed To Reduce the Incidence of Graft-Versus-Host Disease (GVHD) after Unrelated Donor Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning.

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children

Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation

Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV + Hodgkin's Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only